Skip to main content
SRZN
NASDAQ Life Sciences

Surrozen Reports $242M Full-Year Net Loss, EPS at -$32.37

feedReported by Reuters
Sentiment info
Negative
Importance info
8
Price
$25.24
Mkt Cap
$216.343M
52W Low
$5.9
52W High
$29.595
Market data snapshot near publication time

summarizeSummary

Surrozen, Inc. has reported a significant full-year net loss of $242.026 million, translating to an EPS of -$32.37. The company also posted an operating income of -$42.092 million with operating expenses reaching $45.569 million. These substantial losses are highly material for a company of Surrozen's size, raising serious questions about its financial health and cash burn rate. Professional traders would view these results as a critical update, potentially impacting the company's valuation and future funding prospects. Investors will now closely monitor the company's cash reserves and any strategic plans to address these significant financial outflows.

At the time of this announcement, SRZN was trading at $25.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $216.3M. The 52-week trading range was $5.90 to $29.60. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed SRZN - Latest Insights

SRZN
Mar 30, 2026, 6:21 PM EDT
Filing Type: 424B5
Importance Score:
7
SRZN
Mar 25, 2026, 8:02 PM EDT
Filing Type: 4
Importance Score:
8
SRZN
Mar 23, 2026, 5:26 PM EDT
Filing Type: S-3
Importance Score:
9
SRZN
Mar 23, 2026, 4:30 PM EDT
Filing Type: 10-K
Importance Score:
9
SRZN
Mar 23, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
SRZN
Mar 23, 2026, 4:05 PM EDT
Source: Reuters
Importance Score:
8
SRZN
Mar 16, 2026, 7:05 PM EDT
Filing Type: 4
Importance Score:
7
SRZN
Jan 22, 2026, 6:55 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
SRZN
Jan 20, 2026, 7:35 PM EST
Filing Type: 4
Importance Score:
7
SRZN
Jan 08, 2026, 5:19 PM EST
Filing Type: 4
Importance Score:
7